Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!_x000D_
_x000D_
How big is the progressive ataxia and weakness disorders market today, and what are its future growth expectations?_x000D_
_x000D_
The progressive ataxia and weakness disorders market size has grown rapidly in recent years. It will grow from $34.72 billion in 2024 to $38.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing awareness and diagnosis, growth in genetic research, increasing government funding, increasing expenditures for health care, and a rise in alcohol and drug use._x000D_
_x000D_
The progressive ataxia and weakness disorders market size is expected to see rapid growth in the next few years. It will grow to $58.68 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to the increasing prevalence of neurological disorders, the rising prevalence of chronic diseases, expanding insurance coverage, and the rising aging population. Major trends in the forecast period include technological advancements, genetic testing, gene therapy, personalized medicine, and the adoption of telemedicine._x000D_
_x000D_
_x000D_
_x000D_
Get Your Free Sample of The Global Progressive Ataxia And Weakness Disorders Market Report:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=18444&type=smp_x000D_
_x000D_
What are the top drivers to the rising demand in the progressive ataxia and weakness disorders market?_x000D_
_x000D_
The increasing prevalence of neurological disorders is expected to propel the growth of the progressive ataxia and weakness disorders market. Neurological disorders are diseases that affect the central and peripheral nervous systems, including the brain, spinal cord, cranial and peripheral nerves, autonomic nervous system, nerve roots, neuromuscular junction, and muscles. The increasing prevalence of neurological disorders is due to the aging population, genetic factors, and infectious diseases. Progressive ataxia and weakness disorders play a crucial role in the field of neurology by guiding diagnosis, treatment, research, and patient care initiatives aimed at improving outcomes and quality of life for individuals affected by these challenging neurological conditions. For instance, in April 2022, according to the European Brain Council, a Belgium-based non-profit organization, the number of Europeans suffering from dementia ( a neurological condition) was 10.5 million in 2022, which is projected to grow to 18.7 million by 2050. Therefore, the increasing prevalence of neurological disorders is driving the progressive ataxia and weakness disorders market._x000D_
_x000D_
How is the progressive ataxia and weakness disorders market segmented?_x000D_
The progressive ataxia and weakness disorders market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Progressive Ataxia, Progressive Weakness Disorders_x000D_
2) By Technology: Small Molecule, Monoclonal Antibody, Other Technology_x000D_
3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy_x000D_
4) By Application: Hospital, Clinic, Other Applications_x000D_
_x000D_
Subsegments:_x000D_
1) By Progressive Ataxia: Cerebellar Ataxia, Sensory Ataxia, Vestibular Ataxia, Friedreich’s Ataxia, Spinocerebellar Ataxia (SCA), Idiopathic Ataxia _x000D_
2) By Progressive Weakness Disorders: Amyotrophic Lateral Sclerosis (ALS), Muscular Dystrophy, Spinal Muscular Atrophy (SMA), Myasthenia Gravis, Multiple Sclerosis (MS), Guillain-Barré Syndrome (GBS)_x000D_
_x000D_
Order your report now for swift delivery_x000D_
_x000D_
Who are the top competitors in the progressive ataxia and weakness disorders market?_x000D_
_x000D_
Major companies operating in the progressive ataxia and weakness disorders market are Pfizer Inc., Merck & Co. Inc., Bristol-Myers Squibb Company, Novartis AG, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Banner Health, Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Kissei Pharmaceutical Co. Ltd., Biohaven Pharmaceutical Holding Company Ltd., Design Therapeutics Inc., Anavex Life Sciences Corp., Larimar Therapeutics Inc., Voyager Therapeutics Inc., Stealth BioTherapeutics Corp., Capsida Biotherapeutics Inc., Retrotope Inc., Taysha Gene Therapies Inc., CRISPR Therapeutics AG _x000D_
_x000D_
What significant trends should we anticipate in the progressive ataxia and weakness disorders market over the forecast period?_x000D_
_x000D_
Major companies operating in the progressive ataxia and weakness disorders market are focused on developing innovative products, such as oral medication for the treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older. Oral medication refers to medications taken by mouth, typically in tablets, capsules, or liquid formulations. For instance, in February 2024, Biogen Inc., a US-based biotechnology company, announced that SKYCLARYS (omaveloxolone) had been approved by the European Commission (EC) to treat Friedreich’s ataxia (FA). SKYCLARYS works by activating the Nrf2 pathway to address Friedreich’s ataxia’s underlying oxidative stress and mitochondrial dysfunction. The medication is taken orally without food and has been shown to improve symptoms and slow disease progression in clinical trials. Common side effects include increased liver enzymes, headaches, nausea, abdominal pain, fatigue, diarrhea, and musculoskeletal pain._x000D_
_x000D_
Which regional trends are influencing the progressive ataxia and weakness disorders market, and which area dominates the industry?_x000D_
_x000D_
North America was the largest region in the progressive ataxia and weakness disorders market in 2023. The regions covered in the progressive ataxia and weakness disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Does The Progressive Ataxia And Weakness Disorders Market Report 2025 Offer?_x000D_
_x000D_
The progressive ataxia and weakness disorders market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities._x000D_
_x000D_
Progressive ataxia and weakness disorders refer to a range of medical conditions characterized by a gradual decline in coordination and muscle strength. These disorders significantly impact a person’s quality of life and often require a multidisciplinary approach to diagnosis and management._x000D_
_x000D_
Purchase the exclusive report now to unlock valuable market insights:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18444_x000D_
_x000D_
About The Business Research Company_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. _x000D_
_x000D_
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making._x000D_
_x000D_
Contact Us:_x000D_
The Business Research Company_x000D_
Europe: +44 207 1930 708_x000D_
Asia: +91 88972 63534_x000D_
Americas: +1 315 623 0293_x000D_
Email: info@tbrc.info_x000D_
_x000D_
Follow Us On:_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
Twitter: https://twitter.com/tbrc_info_x000D_
Facebook: https://www.facebook.com/TheBusinessResearchCompany_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Blog: https://blog.tbrc.info/_x000D_
Healthcare Blog: https://healthcareresearchreports.com/_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
